Structure | Chemical Name | CAS | MF |
|
(1S,4R)-N-Desmethyl Sertraline Hydrochloride
|
675126-07-5
|
C16H16Cl3N
|
|
1-[(1S,2R)-2-[N-(3,4-Dichlorophenylacetyl)-N-methylamino]-1-methylpropyl]pyrrolidinium
|
|
C17H25Cl2N2O+
|
|
(4S,7S)-1,3,4,5,7,8,10,11,12,13-Decahydro-4-(hydroxymethyl)-8,10,10,13,13-pentamethyl-7-isopropyl-6H-benzo[g][1,4]diazonino[7,6,5-cd]indol-6-one
|
|
C25H37N3O2
|
|
(3S,5S)-3,5-Decanediol
|
|
C10H22O2
|
|
S,S'-DECAMETHYLENEBIS(BENZENETHIOSULFONATE)
|
|
C22H30O4S4
|
|
S,S'-DECAMETHYLENEBIS(P-TOLUENETHIOSULFONATE)
|
|
C24H34O4S4
|
|
(2S,5S)-8-DECYLBENZOLACTAM V
|
|
|
|
(1S,2S)-2-Decyloxycyclohexanol propionate
|
|
C19H36O3
|
|
(2S)-1-[[(1S)-Decahydro-5,5,8aβ-trimethyl-2-methylenenaphthalen]-1β-yl]propan-2-ol
|
|
|
|
SS-DEFENSIN1,AA1-5,RABBITANTI-HUMAN:ELISA
|
|
|
|
SS-DEFENSIN5,AA17-51,RABBITANTI-HUMAN:ELISA
|
|
|
|
SS-DEFENSIN1,AA1-5,HUMANSYNTHETICPEPTIDE
|
|
|
|
SS-DEFENSIN1,AA18-26,HUMANSYNTHETICPEPTIDE
|
|
|
|
SS-DEFENSIN4,AA3-39,HUMANSYNTHETICPEPTIDE
|
|
|
|
SS-DEFENSIN3,AA6-22,HUMANSYNTHETICPEPTIDE
|
|
|
|
SS-DEFENSIN1,AA18-26,RABBITANTI-HUMAN
|
|
|
|
SS-DEFENSIN2,AA4-41,HUMANSYNTHETICPEPTIDE
|
|
|
|
SS-DEFENSIN6,AA1-38,RABBITANTI-HUMAN:ELISA
|
|
|
|
SS-DEFENSIN1,AA1-36,HUMANSYNTHETICPEPTIDE
|
|
|
|
SS-DEFENSIN1,AA28-34,HUMANSYNTHETICPEPTIDE
|
|
|
|
SS-DEFENSIN1,AA1-36,CLONE:M11-14B-D10,MABANTI-HUMAN:ELISA/WB
|
|
|
|
SS-DEFENSIN3,AA6-22,CLONE:L3-18B-E1,MABANTI-HUMAN:RIA/ELISA
|
|
|
|
SS-DEFENSIN1,AA28-34,RABBITANTI-HUMAN
|
|
|
|
SS-DEFENSIN4,AA3-39,CLONE:L13-10-D1,MABANTI-HUMAN:PARAFFIN,ELISA/RIA/IHC/WB
|
|
|
|
SS-DEFENSIN2,AA4-41,CLONE:L12-4C-C2,MABANTI-HUMAN:ELISA
|
|
|
|
SS Column 1.25ft 30% DC-200 Chromosorb(R) PNAW, General Coil
|
|
|
|
SS COL 6FT 1/8IN 60/80 MOLSIEVE 5A, GENERAL COIL
|
|
|
|
SS Column 1.5ft 30% DC-200 80/100 Chromosorb(R) PNAW, General Coil
|
|
|
|
SS Column 10ft General Coil 80/100 PorapakTM Q, General Coil
|
|
|
|
SS Column 1.5m 1.16in x .05 ID 80/100Molsieve 5A, Preconditioned
|
|
|
|
SS Column 24ft 30% DC-200 80/100 Chromosorb(R) PNAW, General Coil
|
|
|
|
SS Column 0.5m 1.2% DC-200 Chromosorb(R) PNAW, General Coil
|
|
|
|
SS Column 10ft 45/60 Molecular Sieve 13X, General Coil
|
|
|
|
SS Column 0.76m 1.2% DC-200 80/100 Chromosorb(R) PNAW, General Coil
|
|
|
|
(12S,13S)-9-Deoxy-12,13-epoxy-12,13-dihydro-9-oxoleucomycin V=3-acetate
|
40625-70-5
|
C37H59NO15
|
|
(12S,13S)-9-Deoxy-12,13-epoxy-12,13-dihydro-9-oxoleucomycin V=3,4''-diacetate
|
58880-22-1
|
C39H61NO16
|
|
(9S,11S)-9-Deoxo-11,12-dideoxy-11-amino-9,12-epoxyerythromycin
|
|
|
|
(12S,13S)-9-Deoxy-12,13-epoxy-12,13-dihydro-9-oxoleucomycin V 3-acetate 4''-propanoate
|
58880-23-2
|
C40H63NO16
|
|
(12S,13S)-9-Deoxy-12,13-epoxy-12,13-dihydro-9-oxoleucomycin V 3-acetate 4''-butanoate
|
58880-24-3
|
C41H65NO16
|
|
(9S,11S)-9-Deoxo-12-deoxy-9,12-epoxyerythromycin
|
|
|
|
(1S,2R)-2-{[4-(4-morpholinylsulfonyl)anilino]carbonyl}cyclohexanecarboxylic acid
|
|
C18H24N2O6S
|
|
S-(+)-Scoulerine
|
|
C19H21NO4
|
|
(2S4R)-N1-(9-FLUORENYLMETHYLOXYCARBONYL)-4-(T-BUTYLOXYCARBONYLAMINOMETHYL)-PIPERIDINE-2-CARBOXYLIC ACID
|
|
C27H32N2O6
|
|
(2S4R)-N1-(9-Fluorenylmethyloxycarbonyl)-4-(t-butyloxycarbonylaminomethyl)-piperidine-2-carboxylic acid
|
|
C27H32N2O6
|
|
(-)-(1S,4R)-N-FMOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
|
220497-65-4
|
C21H19NO4
|
|
(-)-(1S,4R)-N-FMOC-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
|
220497-64-3
|
C21H19NO4
|
|
(+)-(1S,3R)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID
|
220497-66-5
|
C21H21NO4
|
|
[2S-[2α(R*),3β]]-N-ForMyl-
|
104872-28-8
|
C29H53NO5
|
|
Ssc1 protein
|
|
|
|
Ssc2 protein, mammalian
|
|
|
|
SRm160 protein
|
|
|
|
Ssc protein
|
134582-73-3
|
|
|
Ssc1 protein, mammalian
|
|
|
|
Srm protein
|
|
|
|
(3S,5S)-3-(β-D-Glucopyranosyloxy)-5-hydroxyhexanoic acid methyl ester
|
|
|
|
(20S,22S)-3β-(β-D-Glucopyranosyloxy)-22-hydroxy-9β,19-cyclolanost-24-ene-26,29-dioic acid δ-lactone
|
124962-06-7
|
C36H54O10
|
|
(2S,3R)-2-[(N-Glycylglycyl)amino]-3-[[(1S)-2-(1H-imidazol-4-yl)-1-carboxyethyl]amino]butyric acid
|
|
C14H22N6O6
|
|
[(22S,25S)-26-(β-D-Glucopyranosyloxy)-22-hydroxy-5β-furostan-3β-yl]4-O-(6-deoxy-α-L-mannopyranosyl)-2-O:6-O-di(β-D-glucopyranosyl)-β-D-glucopyranoside
|
24333-07-1
|
C57H96O28
|
|
[(24S,25S)-24-(β-D-Glucopyranosyloxy)-2α-hydroxyspirost-5-en-3β-yl]4-O-[2-O-(β-D-glucopyranosyl)-3-O-[4-O-(β-D-glucopyranosyl)-β-D-xylopyranosyl]-β-D-glucopyranosyl]-β-D-galactopyranoside
|
89899-85-4
|
C56H90O29
|
|
(1S,7S)-1-(β-D-Glucopyranosyloxy)-1,4aα,5,6,7,7aα-hexahydro-7-hydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester
|
64421-27-8
|
C17H26O10
|
|
(2S,3S)-6-[2-(β-D-Glucopyranosyloxy)ethyl]-2,3-dihydro-3-hydroxy-5,7-bis(hydroxymethyl)-2-methyl-1H-inden-1-one
|
62043-52-1
|
C20H28O10
|
|
(2S)-(-)- RO-363
|
|
|
|
(S,S)-2,8-Diazabicyclo[4.3.0]nonane dihydrochloride
|
|
C7H16Cl2N2
|
|
(5S,18S)-1,22-DiaMino-7,16-dioxo-6,8,15,17-tetraazadocosane-5,18-dicarboxylic Acid
|
1417789-80-0
|
C20H40N6O6
|
|
(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone
|
14842-41-2
|
C10H10N2O4
|
|
(1S,4S)-2,5-DIAZABICYCLO[2.2.1]HEPTANE DIHYDROBROMIDE
|
100944-14-7
|
C5H12Br2N2
|
|
(5S,2S)-2,5-Diaminoadipic acid 2HCl
|
188181-71-7
|
C6H13ClN2O4
|
|
(8S,2S)-Diaminononanedioic acid
|
159344-56-6
|
C9H18N2O4
|
|
(2S,4S)-Diaminoglutaric acid 2HCl
|
159206-44-7
|
C5H12Cl2N2O4
|
|
(1S,4S)-2,5-Diazabicyclo[2.2.1]heptane
|
132339-20-9
|
C5H10N2
|
|
(S,S)-2,8-Diazabicyclo[4,3,0]nonane
|
151213-42-2
|
C7H14N2
|
|
1-[(2S,6S)-2,6-diallyl-4-methyl-3,6-dihydro-1(2H)-pyridinyl]-3,3,4,4,5,5,5-heptafluoro-2-pentanol
|
|
C17H22F7NO
|
|
1-[(2S,6S)-2,6-diallyl-3,6-dihydro-1(2H)-pyridinyl]-1-ethanone
|
|
C13H19NO
|
|
(2S,6S)-2,6-diallyl-4-methyl-1,2,3,6-tetrahydropyridine hydrochloride
|
|
C12H20ClN
|
|
1-[(2S,6S)-2,6-diallyl-4-methyl-3,6-dihydro-1(2H)-pyridinyl]-1-ethanone
|
|
C14H21NO
|
|
(2S,6S)-2,6-diallyl-1,1-dimethyl-1,2,3,6-tetrahydropyridinium iodide
|
|
C13H22IN
|
|
1-[(2S,6S)-2,6-diallyl-3,6-dihydro-1(2H)-pyridinyl]-2,2,2-trifluoro-1-ethanone
|
|
C13H16F3NO
|
|
(2S,6S)-2,6-diallyl-4-benzyl-1,2,3,6-tetrahydropyridine hydrochloride
|
|
C18H24ClN
|
|
(6S,2S)-Diaminopimelic acid
|
14289-34-0
|
C7H14N2O4
|
|
(3S,2S)-2,3-Diaminobutyric acid 2HCl
|
121054-30-6
|
C4H11ClN2O2
|
|
(1S,4S)-2,5-DIAZABICYCLO(2.2.2)OCTANE
|
194600-16-3
|
C6H12N2
|
|
(1S,2S)-(-)-1,2-DIAMINOCYCLOHEXANE-N,N'-BIS(2'-DIPHENYLPHOSPHINOBENZOYL)
|
169689-05-8
|
C44H40N2O2P2
|
|
(2S,6S)-2,6-DIALLYL-4-VINYL-1,2,3,6-TETRAHYDROPYRIDINE
|
|
C13H19N
|
|
(1S,4S)-4-(2,5-DIAZA-BICYCLO[2.2.1]HEPT-2-YLMETHYL)-BENZONITRILE
|
|
C13H15N3
|
|
[(S,S)-1,5-DIAZA-CIS-DECALIN]COPPER HYDROXIDE IODIDE HYDRATE
|
|
C8H19CuIN2O2
|
|
1S, 2S-(+)-1,2-DIAMINOCYCLOHEXANE TRITYL RESIN
|
|
|
|
(4S,5S)-4,5-DI(AMINOMETHYL)-2,2-DIMETHYLDIOXOLANE
|
|
C7H16N2O2
|
|
(1S,4S)-(+)-[4-(2,5-DIAZA-BICYCLO[2.2.1]HEPT-2-YLMETHYL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER 2CF3COOH
|
845866-71-9
|
C17H25N3O2
|
|
(2S,3S)-2,3-Diaminobutyric acid
|
|
C4H10N2O2
|
|
(1S,6S)-2β,3α-Diacetoxy-1-[(benzoyloxy)methyl]-7-oxabicyclo[4.1.0]hept-4-ene
|
17550-38-8
|
C18H18O7
|
|
(2S,3S)-2,3-Diacetoxy-2-(1-methylethyl)butanoic acid [(1R,7aα)-hexahydro-1H-pyrrolizin]-1α-ylmethyl ester
|
|
|
|
(1S,2S)-3'β,9'α-Diacetoxy-10'β-hydroxy-2,4'bα,8',8'-tetramethyl-5',6',8',8'aβ,9',10'-hexahydrospiro[cyclopropane-1,2'(1'H)-phenanthrene]-1',4',7'(3'H,4'bH)-trione
|
41059-82-9
|
C24H30O8
|
|
(13S,17S)-1α,7α-Diacetoxy-12α-[(2-acetoxy-3-methyl-1-oxopentyl)oxy]-21,23-epoxy-4a,4a,8-trimethyl-A-homo-24-nor-4-oxa-5α-chola-14,20,22-trien-3-one
|
77887-63-9
|
C38H52O11
|
|
(2S,3S)-2,3-Diamino-4-phenylbutanoic acid
|
|
C10H14N2O2
|
|
(9S,11S)-4',11-Diamino-9-deoxo-4',11,12-trideoxy-9,12-epoxyerythromycin
|
|
|
|
(3S,10S)-5,8-Diazadodecane-3,10-diol
|
|
C10H24N2O2
|
|
(13S,17S,20ξ)-6α,7α-Diacetoxy-21,23-epoxy-23-hydroxy-4,4,8-trimethyl-24-nor-5α-chola-1,14-dien-3-one
|
73114-37-1
|
C30H42O7
|
|
(2S,3S)-2,3-DIAMINOBUTANE-1,4-DIOL
|
151630-98-7
|
C4H12N2O2
|
|
(2S,6S)-2,6-DIALLYL-4-METHYL-1,2,3,6-TETRAHYDROPYRIDINE
|
157056-58-1
|
C12H19N
|
|
(1S,4S)-4-(2,5-Diaza-bicyclo[2.2.1]hept-2-
|
|
|